These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3354443)

  • 21. Results of electrophysiologic testing and long-term prognosis in patients with coronary artery disease and aborted sudden death.
    Sousa J; Rosenheck S; Calkins H; de Buitleir M; Schmaltz S; Kadish A; Morady F
    Am Heart J; 1991 Oct; 122(4 Pt 1):1001-6. PubMed ID: 1927851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and electrophysiologic determinants, treatment and survival of patients with sustained malignant ventricular tachyarrhythmias occurring late after myocardial infarction.
    Gomes JA; Winters SL; Ergin A; Machac J; Estioko M; Alexopoulous D; Pe E
    J Am Coll Cardiol; 1991 Feb; 17(2):320-6. PubMed ID: 1991887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Watson RM; Schwartz JL; Maron BJ; Tucker E; Rosing DR; Josephson ME
    J Am Coll Cardiol; 1987 Oct; 10(4):761-74. PubMed ID: 3655144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms determining sudden death. A cooperative study of 69 cases recorded using the Holter method].
    Leclercq JF; Coumel P; Maison-Blanche P; Cauchemez B; Zimmermann M; Chouty F; Slama R
    Arch Mal Coeur Vaiss; 1986 Jun; 79(7):1024-33. PubMed ID: 3096225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proarrhythmic response to antiarrhythmic drug as a risk factor for sudden cardiac death in patients with ischemic heart disease.
    Trusz-Gluza M; Giec L; Dabrowski A; Kuch J; Pasyk S; Piwowarska W; Pracka H; Sadowski Z; Wodniecki J
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1947-50. PubMed ID: 1721204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands.
    Willems AR; Tijssen JG; van Capelle FJ; Kingma JH; Hauer RN; Vermeulen FE; Brugada P; van Hoogenhuyze DC; Janse MJ
    J Am Coll Cardiol; 1990 Sep; 16(3):521-30. PubMed ID: 2201710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival after prehospital cardiac arrest: analysis of outcome during an 8 year study.
    Myerburg RJ; Kessler KM; Estes D; Conde CA; Luceri RM; Zaman L; Kozlovskis PL; Castellanos A
    Circulation; 1984 Oct; 70(4):538-46. PubMed ID: 6541102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
    Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
    Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.
    Gradman A; Deedwania P; Cody R; Massie B; Packer M; Pitt B; Goldstein S
    J Am Coll Cardiol; 1989 Sep; 14(3):564-70; discussion 571-2. PubMed ID: 2768707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic Study Versus Electromagnetic Monitoring.
    Caruso AC; Marcus FI; Hahn EA; Hartz VL; Mason JW
    Circulation; 1997 Sep; 96(6):1888-92. PubMed ID: 9323077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of patients at high risk of sudden death.
    Lown B
    Am Heart J; 1982 Apr; 103(4 Pt 2):689-97. PubMed ID: 6175197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of sudden death risk factors in acute and chronic coronary artery disease.
    Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden death during ambulatory monitoring.
    Lahiri A; Balasubramanian V; Raftery EB
    Br Med J; 1979 Jun; 1(6179):1676-8. PubMed ID: 88992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of silent ischemia, the arrhythmic substrate and the short-long sequence in the genesis of sudden cardiac death.
    Gomes JA; Alexopoulos D; Winters SL; Deshmukh P; Fuster V; Suh K
    J Am Coll Cardiol; 1989 Dec; 14(7):1618-25. PubMed ID: 2584549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.